SCHEDULE 13D

CUSIP Number(s):

888705308

1

Name of reporting person

3i, LP

2

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

3

SEC use only

4

Source of funds (See Instructions)

WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 3,334,139.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 3,334,139.00

11

Aggregate amount beneficially owned by each reporting person

3,334,139.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

13

Percent of class represented by amount in Row (11)

9.9 %

14

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person:

As more fully described in Item 5 of this Amendment No. 5 (as defined in Item 1 below), such shares and percentage are based on 32,140,634 shares of common stock, par value $0.0001 per share, of the Issuer (the "Common Stock") outstanding as of August 24, 2026, as verified with the Issuer. Beneficial ownership consists of 2,100,000 shares of Common Stock directly held by 3i, LP and 1,234,139 shares of Common Stock issuable in any combination upon (i) exercises of certain common stock purchase warrants (the "Warrants") held directly by 3i, LP, which exercises are subject to a 9.99% beneficial ownership limitation provision (a "Blocker"), (ii) conversions of a senior secured convertible note in the original principal amount of $16,253,147.10 (the "Note") held directly by 3i, LP, which conversions are subject to a Blocker, (iii) conversions of shares of Series B Convertible Preferred Stock, par value $0.0001 per share, of the Issuer (the "Series B Preferred Stock") directly held by 3i, LP, which conversions are subject to a Blocker, and (iv) conversions of shares of Series C Convertible Preferred Stock, par value $0.0001 per share, of the Issuer (the "Series C Preferred Stock") directly held by the 3i, LP, which conversions are subject to a Blocker.

SCHEDULE 13D

CUSIP Number(s):

888705308

1

Name of reporting person

Tumim Stone Capital, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

3

SEC use only

4

Source of funds (See Instructions)

WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

13

Percent of class represented by amount in Row (11)

0.00 %

14

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13D

CUSIP Number(s):

888705308

1

Name of reporting person

3i Management LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

3

SEC use only

4

Source of funds (See Instructions)

WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 3,334,139.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 3,334,139.00

11

Aggregate amount beneficially owned by each reporting person

3,334,139.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

13

Percent of class represented by amount in Row (11)

9.9 %

14

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person:

As more fully described in Item 5 of this Amendment No. 5, such shares and percentage are based on 32,140,634 shares of Common Stock outstanding as of August 24, 2026, as verified with the Issuer. Beneficial ownership consists of 2,100,000 shares of Common Stock indirectly held by the reporting person and 1,234,139 shares of Common Stock issuable in any combination upon (i) exercises of the Warrants indirectly held by the reporting person, which exercises are in each case subject to a Blocker, and (ii) conversions of the Note, shares of Series B Preferred Stock and shares of Series C Preferred Stock indirectly held by the reporting person, which conversions are in each case subject to a Blocker.

SCHEDULE 13D

CUSIP Number(s):

888705308

1

Name of reporting person

Maier J. Tarlow

2

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

3

SEC use only

4

Source of funds (See Instructions)

WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 3,334,139.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 3,334,139.00

11

Aggregate amount beneficially owned by each reporting person

3,334,139.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

13

Percent of class represented by amount in Row (11)

9.9 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

As more fully described in Item 5 of this Amendment No. 5, such shares and percentage are based on 32,140,634 shares of Common Stock outstanding as of August 24, 2026, as verified with the Issuer. Beneficial ownership consists of 2,100,000 shares of Common Stock indirectly held by the reporting person and 1,234,139 shares of Common Stock issuable in any combination upon (i) exercises of the Warrants indirectly held by the reporting person, which exercises are in each case subject to a Blocker, and (ii) conversions of the Note, shares of Series B Preferred Stock and shares of Series C Preferred Stock indirectly held by the reporting person, which conversions are in each case subject to a Blocker.

SCHEDULE 13D

Item 1.

Security and Issuer

(a)

Title of Class of Securities:

Common Stock

(b)

Name of Issuer:

Valion Bio, Inc.

(c)

Address of Issuer's Principal Executive Offices:

1305 E. Houston Street, Building 1, Suite 311, San Antonio, TEXAS , 78205.

Item 1 Comment:

This Amendment No. 5 to Schedule 13D (this "Amendment No. 5") relates to the common stock, par value $0.0001 per share (the "Common Stock") of Valion Bio, Inc., a Delaware corporation (the "Issuer"), and amends the Schedule 13D filed on August 3, 2026, as amended by Amendment No. 1 filed on August 11, 2026, Amendment No. 2 filed on August 14, 2026, Amendment No. 3 filed on August 19, 2026 and Amendment No. 4 filed on August 24, 2026 (as amended, the "Original Schedule 13D") by (a) 3i, LP, (b) Tumim Stone Capital, LLC ("Tumim Stone"), (c) 3i Management LLC ("3i Management") and (d) Maier J. Tarlow ("Mr. Tarlow" and, together with 3i, LP, 3i Management and Tumim Stone, the "Reporting Persons") as set forth herein.

Item 2.

Identity and Background

(a)

This Item 2(a) is not being amended by this Amendment No. 5.

(b)

This Item 2(b) is not being amended by this Amendment No. 5.

(c)

This Item 2(c) is not being amended by this Amendment No. 5.

(d)

This Item 2(d) is not being amended by this Amendment No. 5.

(e)

This Item 2(e) is not being amended by this Amendment No. 5.

(f)

This Item 2(f) is not being amended by this Amendment No. 5.

Item 3.

Source and Amount of Funds or Other Consideration

This Item 3 is not being amended by this Amendment No. 5.

Item 4.

Purpose of Transaction

This Item 4 is not being amended by this Amendment No. 5.

Item 5.

Interest in Securities of the Issuer

(a)

Item 5(a) of the Original Schedule 13D is hereby amended and restated as follows: See rows (11) and (13) of the cover pages to this statement for the aggregate number of shares of Common Stock and percentages of the shares of Common Stock beneficially owned by each of the Reporting Persons. The shares and percentages are based on 32,140,634 shares of Common Stock outstanding as of August 24, 2026, as verified with the Issuer.

(b)

This Item 5(b) is not being amended by this Amendment No. 5.

(c)

This Item 5(c) is hereby amended to add the transactions set forth in Exhibit 9 attached herein.

(d)

This Item 5(d) is not being amended by this Amendment No. 5.

(e)

This Item 5(e) is not being amended by this Amendment No. 5.

Item 6.

Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer

This Item 6 is not being amended by this Amendment No. 5.

Item 7.

Material to be Filed as Exhibits.

Item 7 of the Original Schedule 13D is hereby amended to add the following exhibit: Exhibit 9: Additional Transactions

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

3i, LP

Signature:	/s/ Maier J. Tarlow
Name/Title:	Maier J. Tarlow, manager of 3i Management LLC, general partner of 3i, LP
Date:	08/27/2026

Tumim Stone Capital, LLC

Signature:	/s/ Maier J. Tarlow
Name/Title:	Maier J. Tarlow, manager of 3i Management LLC, manager of Tumim Stone Capital, LLC
Date:	08/27/2026

3i Management LLC

Signature:	/s/ Maier J. Tarlow
Name/Title:	Maier J. Tarlow, Manager
Date:	08/27/2026

Maier J. Tarlow

Signature:	/s/ Maier J. Tarlow
Name/Title:	Maier J. Tarlow
Date:	08/27/2026